# GADOTERATE MEGLUMINE
> **ANDA219286** · Abbreviated New Drug Application (Generic) · Sponsor: VIWIT PHARM · Approved 2026-08-10
## Drug
- **FDA Application Number:** ANDA219286
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GADOTERATE MEGLUMINE
- **Generic name:** Gadoterate Meglumine
- **Active ingredients:** GADOTERATE MEGLUMINE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** VIWIT PHARM
- **First approval:** 2026-08-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219286)
---
*MORVS · CC0 1.0*